Roche Holding AG (OTCMKTS:RHHBY) Position Raised by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC lifted its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 2.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,091 shares of the company’s stock after acquiring an additional 304 shares during the period. HighPoint Advisor Group LLC’s holdings in Roche were worth $387,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Brooklyn Investment Group increased its position in Roche by 36.6% in the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock valued at $48,000 after acquiring an additional 363 shares during the period. IHT Wealth Management LLC acquired a new position in shares of Roche during the third quarter valued at $236,000. Verity Asset Management Inc. raised its stake in shares of Roche by 26.8% during the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock valued at $280,000 after purchasing an additional 1,697 shares in the last quarter. Confluence Investment Management LLC lifted its holdings in Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after purchasing an additional 2,910 shares during the period. Finally, SVB Wealth LLC bought a new position in Roche in the 4th quarter valued at about $555,000.

Analyst Ratings Changes

A number of analysts have commented on the stock. Morgan Stanley began coverage on shares of Roche in a research report on Wednesday, February 12th. They set an “equal weight” rating on the stock. UBS Group upgraded Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 13th. Finally, Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.

Roche Trading Down 4.2 %

Shares of RHHBY opened at $39.37 on Thursday. Roche Holding AG has a 12-month low of $29.20 and a 12-month high of $44.31. The firm’s 50 day moving average is $41.37 and its 200-day moving average is $38.73. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.